CVE-2023-42666

Name: CVE-2023-42666
Creator: NVD / NIST
Published: 2023-10-19T19:15:15.68+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 5.3/10EPSS 0.38%

Last modified Jun 17, 2026

CVE-2023-42666 is a medium-severity vulnerability rated 5.3/10 on the CVSS scale. The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used. . EPSS estimates a 0.38% chance of exploitation in the next 30 days.

Description

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Metrics

CVSS 3.1

5.3/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

EPSS Probability

0.38%

30.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-200

Affected Software

Vendor	Product	Versions
Dexma	Dexgate	20130114

References

https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource

Timeline

Published: Oct 19, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-42666?

How severe is CVE-2023-42666?

CVE-2023-42666 has a CVSS score of 5.3/10 (MEDIUM severity). The EPSS model estimates a 0.38% probability of exploitation in the next 30 days.

How do I fix CVE-2023-42666?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-42666?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST